Spero Therapeutics's total assets for Q1 2025 were $77.71M, a decrease of -29.70% from the previous quarter. SPRO total liabilities were $43.90M for the fiscal quarter, a -31.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.